UNIGE document Scientific Article
previous document  unige:99458  next document
add to browser collection
Title

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Authors
Chatzidionysiou, Katerina
Lie, Elisabeth
Nasonov, Evgeny
Lukina, Galina
Hetland, Merete Lund
Tarp, Ulrik
Ancuta, Ioan
Pavelka, Karel
show hidden authors show all authors [1 - 16]
Published in Arthritis Research and Therapy. 2016, vol. 18, p. 50
Abstract The approved dose of rituximab (RTX) in rheumatoid arthritis is 1000 mg × 2, but some data have suggested similar clinical efficacy with 500 mg × 2. The purpose of this study was to compare the effectiveness of the regular and low doses given as first treatment course.
Keywords AdultAgedAntirheumatic Agents/administration & dosageArthritisRheumatoid/diagnosis/drug therapy/epidemiologyCohort StudiesCooperative BehaviorDatabasesFactualDose-Response RelationshipDrugEurope/epidemiologyFemaleHumansInternationalityMaleMiddle AgedRegistriesRituximab/administration & dosageStatistics as Topic/methodsTreatment Outcome
Identifiers
PMID: 26883119
Full text
Article (Published version) (713 Kb) - public document Free access
Structures
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format)
CHATZIDIONYSIOU, Katerina et al. Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration. In: Arthritis Research and Therapy, 2016, vol. 18, p. 50. https://archive-ouverte.unige.ch/unige:99458

28 hits

5 downloads

Update

Deposited on : 2017-11-22

Export document
Format :
Citation style :